IL17A and metabolic dysfunction-associated steatotic liver disease: Moreover, genome-wide association studies (GWAS) revealed single nucleotide polymorphisms (SNPs) in key IL-17 axis pathways, including RORγt, STAT4, and IL-17R that were associated with the severity of human MASLD and hepatobiliary disease (153, 154).